Teladoc Health Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
TDOC$8.94-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Other Comprehensive Loss
(in thousands, except share and per share data)
| Year EndedDecember 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Revenue | $2,569,574 | $2,602,415 | $2,406,840 |
| Costs and expenses: | |||
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 751,270 | 760,031 | 743,987 |
| Advertising and marketing | 705,787 | 688,854 | 623,536 |
| Sales | 204,993 | 213,780 | 227,172 |
| Technology and development | 307,274 | 348,521 | 333,629 |
| General and administrative | 435,490 | 464,659 | 449,855 |
| Goodwill impairment | 790,000 | — | 13,402,812 |
| Acquisition, integration, and transformation costs | 1,743 | 21,110 | 15,620 |
| Restructuring costs | 20,355 | 16,942 | 7,416 |
| Amortization of intangible assets | 363,365 | 325,933 | 244,620 |
| Depreciation of property and equipment | 10,183 | 11,138 | 11,407 |
| Total costs and expenses | 3,590,460 | 2,850,968 | 16,060,054 |
| Loss from operations | (1,020,886) | (248,553) | (13,653,214) |
| Interest income | (57,071) | (46,782) | (12,674) |
| Interest expense | 23,803 | 22,282 | 21,944 |
| Other expense (income), net | 6,035 | (4,445) | 859 |
| Loss before provision for income taxes | (993,653) | (219,608) | (13,663,343) |
| Provision for income taxes | 7,592 | 760 | (3,812) |
| Net loss | (1,001,245) | (220,368) | (13,659,531) |
| Other comprehensive loss, net of tax: | |||
| Currency translation adjustment | (1,398) | 5,786 | (36,491) |
| Comprehensive loss | $(1,002,643) | $(214,582) | $(13,696,022) |
| Net loss per share, basic and diluted | $(5.87) | $(1.34) | $(84.60) |
| Weighted-average shares used to compute basic and diluted net loss per share | 170,564,088 | 164,578,219 | 161,457,123 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.